Wealth Effects’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wealth Effects's LLY Position: Q2 2026 in Review
Wealth Effects increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $8.17K and bringing the position to 742 shares worth $890K. The position accounts for 0.24% of the portfolio, ranked #80.
Wealth Effects first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.48M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wealth Effects held 742 shares of Eli Lilly worth $890K as of Q2 2026.
- Wealth Effects bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
- Eli Lilly made up 0.24% of Wealth Effects's portfolio in Q2 2026, its #80 holding.
- Wealth Effects first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- Wealth Effects's Eli Lilly position peaked at $2.48M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.